Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Dianabol boosts muscle growth but has serious health risks and legal issues.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Gene mutations can cause problems in male genital development.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.